Search

Hendri Tjandra

from Union City, CA
Age ~58
Get Report
Also known as:
Hendri Canada
Phone and address:
32713 Jean Dr, Union City, CA 94587
(510) 468-6688
Related to:
Michael Canada, 57Michelle M Canada, 56Gregory Todd Altemose, 58Suzanne R Canada, 57
Connected to:
Berdy T Tjandramulia, 59Djinto T Tjandra, 66Evan U Tjandra, 45Lilin Tjandra, 56Melissa F Tjandra, 31Patricia A Tjandra, 45Ricky F Tjandra, 44Michael J Tjapkes, 37Michelle R Tjardes, 50Aaron M Tjarks, 35

Hendri Tjandra Phones & Addresses

  • 32713 Jean Dr, Union City, CA 94587 (510) 468-6688 (510) 324-8968
  • 958 Apricot Ave, Campbell, CA 95008
  • 20 Blake Ln, Scotts Valley, CA 95066
  • Lafayette, IN
  • Berkeley, CA
  • W Lafayette, IN
  • Alameda, CA
  • Santa Clara, CA
  • 32713 Jean Dr, Union City, CA 94587

Resumes

Resumes

Hendri Tjandra Photo 1

Senior Staff Scientist P.d

View page
Location:
32713 Jean Dr, Union City, CA 94587
Industry:
Biotechnology
Work:
Bayer 2004 - 2006
Senior Scientist I
Bayer 2004 - 2006
Senior Staff Scientist P.d
Bayer 2001 - 2004
Pd Scientist
Sanofi Mar 2000 - Dec 2000
Scientist
Uc Santa Cruz Sep 1996 - Feb 2000
Postdoctoral Researcher In the Laboratory of Douglas R Kellogg, Uc Santa Cruz
Education:
Catholic Junior College, Singapore
St Joseph's Institution (Sji)
Catholic Junior College
University of California, Santa Cruz
University of California, Davis
Bachelors, Bachelor of Science, Biochemistry Purdue University
Doctorates, Doctor of Philosophy, Biology, Biochemistry
Skills:
Purification
Protein Chemistry
Protein Purification
Gmp
Chromatography
Downstream Processing
Affinity Chromatography
Filtration
Sop
Ind
Fplc
Cmc
Cgmp Manufacturing
Akta
Size Exclusion
Ion Exchange
Process Transfer
Protein Chromatography
Bioprocess
Unicorn
Bioconjugation
Mass Spectrometry
Bioseparations
Protein Kinases
Clinical Manufacturing
Cmo Management
Processes Development
Nanofiltration
Protein Conjugation
Depth Filtration
Hybridoma
Viral Clearance
Pegylation
Conjugation
Uf/Df
Ultrafiltration
Tff
Process Robustness
Cell Cycle
Mitotic Cyclins
Phosphatase Pp2A
Dyneins
Motor Proteins
Cytoskeletal Proteins
Microtubules
Maps
Mt Associated Proteins
Pak Kinases
P21 Activated Kinases
Interests:
Photograph
Boating
Electronics
Outdoors
Home Improvement
Reading
Science and Technology
Music
Sports
The Arts
Travel
Movies
Home Decoration
Languages:
Indonesian
Spanish
Hendri Tjandra Photo 2

Hendri Tjandra

View page

Publications

Us Patents

Site-Directed Modification Of Fviii

View page
US Patent:
20060115876, Jun 1, 2006
Filed:
Nov 14, 2005
Appl. No.:
11/273896
Inventors:
Clark Pan - Castro Valley CA, US
John Murphy - Berkeley CA, US
Baisong Mei - Danville CA, US
Jonathan Strauss - Walnut Creek CA, US
Hendri Tjandra - Union City CA, US
Jianmin Chen - Concord CA, US
Thomas Barnett - Chapel Hill NC, US
Liang Tang - Richmond CA, US
Deqian Wang - Concord CA, US
Assignee:
Bayer HealthCare LLC - Berkeley CA
International Classification:
C12P 21/06
C07H 21/04
C07K 14/745
US Classification:
435069100, 435320100, 435325000, 530383000, 536023200
Abstract:
This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain FVIII procoagulant activity and have improved pharmacokinetic properties.

Continuation - Site Directed Modification Of Fviii

View page
US Patent:
20100081615, Apr 1, 2010
Filed:
Aug 13, 2009
Appl. No.:
12/540703
Inventors:
Clark Q. Pan - Castro Valley CA, US
John E. Murphy - Berkeley CA, US
Baisong Mei - Danville CA, US
Jonathan S. Strauss - Walnut Creek CA, US
Hendri Tjandra - Union City CA, US
Jianmin Chen - Concord CA, US
Thomas Barnett - Chapel Hill NC, US
Liang Tang - Richmond CA, US
Deqian Wang - Concord CA, US
Assignee:
Bayer HealthCare LLC - Berkeley CA
International Classification:
C07K 14/755
A61K 38/37
C12P 21/02
US Classification:
514 12, 530383, 435 696
Abstract:
This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain FVIII procoagulant activity and have improved pharmacokinetic properties.

Factor Viii Conjugates

View page
US Patent:
20130274445, Oct 17, 2013
Filed:
Jan 24, 2013
Appl. No.:
13/748983
Inventors:
John E. Murphy - Berkeley CA, US
Baisong Mei - Danville CA, US
Jonathan S. Strauss - Walnut Creek CA, US
Hendri Tjandra - Union City CA, US
Jianmin Chen - Concord CA, US
Thomas Barnett - Chapel Hill NC, US
Liang Tang - Richmond CA, US
Deqian Wang - Concord CA, US
International Classification:
C07K 17/08
US Classification:
530383
Abstract:
This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain FVIII procoagulant activity and have improved pharmacokinetic properties.

Methods Of Treating Hemophilia In Patients Having Developed Inhibitory Antibodies

View page
US Patent:
20160051633, Feb 25, 2016
Filed:
Jul 20, 2015
Appl. No.:
14/803677
Inventors:
- Whippany NJ, US
John E. MURPHY - Berkeley CA, US
Baisong MEI - Danville CA, US
Jonathan S. STRAUSS - Walnut Creek CA, US
Hendri TJANDRA - Union City CA, US
Jianmin CHEN - Concord CA, US
Thomas BARNETT - Chapel Hill NC, US
Liang TANG - Richmond CA, US
Deqian WANG - Concord CA, US
Assignee:
BAYER HEALTHCARE LLC - Whippany NJ
International Classification:
A61K 38/37
A61K 47/48
Abstract:
This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain FVIII procoagulant activity and have improved pharmacokinetic properties.
Control profile
Hendri Tjandra from Union City, CA, age ~58 Get Report